BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6127888)

  • 1. Echocardiographic comparison between prenalterol and dobutamine.
    Wester HA; Oltmanns D
    Acta Med Scand Suppl; 1982; 659():181-90. PubMed ID: 6127888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic effects of prenalterol in diabetic patients.
    Oltmanns D
    Acta Med Scand Suppl; 1982; 659():147-55. PubMed ID: 6127885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous prenalterol in acute and chronic heart failure.
    Kirlin PC; Pitt B; Lucchesi BR
    Acta Med Scand Suppl; 1982; 659():263-86. PubMed ID: 6127894
    [No Abstract]   [Full Text] [Related]  

  • 4. Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity?
    Wirtzfeld A; Klein G; Bibra HV; Sauer E
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):20-7. PubMed ID: 2859252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hemodynamic actions of prenalterol in left ventricular failure.
    Awan NA; Evenson MK; Needham KE; Mason DT
    Acta Med Scand Suppl; 1982; 659():251-61. PubMed ID: 6127893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic effects, plasma concentrations and tolerance of orally administered prenalterol in man.
    Weiss A; Pfister B; Imhof P; Degen PH; Burckhardt D; Dubach UC
    Eur J Clin Pharmacol; 1980 Nov; 18(5):383-90. PubMed ID: 6108221
    [No Abstract]   [Full Text] [Related]  

  • 7. Prenalterol as an antidote to massive doses of metoprolol--a cardiovascular study in the dog.
    Andersson T; Heath A; Mattsson H
    Acta Med Scand Suppl; 1982; 659():71-88. PubMed ID: 6127900
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.
    Rasmussen S; Høilund-Carlsen PF; Hesse B; Hartling OJ; Fabricius J; Dige-Petersen H; Giese J
    Eur J Clin Pharmacol; 1984; 27(5):539-43. PubMed ID: 6151507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioselectivity of dobutamine and prenalterol in the pentobarbital anesthetized dog.
    Strosberg AM; Montgomery W
    Proc West Pharmacol Soc; 1981; 24():83-7. PubMed ID: 7255492
    [No Abstract]   [Full Text] [Related]  

  • 10. Circulatory response to prenalterol in normal subjects and in patients with primary congestive cardiomyopathy.
    Guazzi MD; Qing LG; Olivari MT; Fiorentini C; Loaldi A; Bartorelli A; Moruzzi P; Polese A
    Acta Med Scand Suppl; 1982; 659():233-50. PubMed ID: 6127892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Echocardiographic measurements of hemodynamic effects and pharmacokinetics of prenalterol (author's transl)].
    Oltmanns D; Wester HA; Stein R
    Z Kardiol; 1981 May; 70(5):394-8. PubMed ID: 6115520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic effects of prenalterol in healthy subjects.
    Johnsson G
    Acta Med Scand Suppl; 1982; 659():109-22. PubMed ID: 6127882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
    Erbel R; Meyer J; Schweizer P; Lambertz H; Voelker W; Effert S
    Acta Med Scand Suppl; 1982; 659():169-80. PubMed ID: 6127887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravenous prenalterol on haemodynamics and myocardial lactate extraction in patients with left ventricular failure.
    Kupper W; Schütt M; Bleifeld W
    Acta Med Scand Suppl; 1982; 659():287-98. PubMed ID: 6127895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative inotropic and chronotropic activity of beta-adrenoceptor stimulants in anaesthetised, areflexic dogs.
    Engel B; Einstein R; Goodman AH
    Eur J Pharmacol; 1983 Jan; 86(3-4):461-6. PubMed ID: 6131828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic pharmacological properties of prenalterol.
    Mattsson H; Hedberg A; Carlsson E
    Acta Med Scand Suppl; 1982; 659():9-37. PubMed ID: 6127902
    [No Abstract]   [Full Text] [Related]  

  • 17. Central and peripheral haemodynamic effects of prenalterol in patients with coronary heart disease.
    Svendsen TL; Carlsen JE; Hartling OJ; Trap-Jensen J
    Clin Physiol; 1981 Oct; 1(5):461-9. PubMed ID: 7199993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic effects of prenalterol in patients with coronary heart disease.
    Hutton I; Murray RG; Boyes RN; Rae AP; Hillis WS
    Br Heart J; 1980 Feb; 43(2):134-7. PubMed ID: 6102468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioselectivity of prenalterol and isoproterenol.
    Jennings G; Bobik A; Oddie C; Hargreaves M; Korner P
    Clin Pharmacol Ther; 1983 Dec; 34(6):749-57. PubMed ID: 6641090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
    Manders WT; Vatner SF; Braunwald E
    J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.